{"id":160,"date":"2007-06-30T20:26:45","date_gmt":"2007-06-30T19:26:45","guid":{"rendered":"http:\/\/www.novacos-law.com\/en\/?p=160"},"modified":"2016-03-30T20:28:10","modified_gmt":"2016-03-30T19:28:10","slug":"das-gkv-wettbewerbsstaerkungsgesetz-staerkung-oder-einschraenkung-des-wettbewerbs-im-arzneimittelmarkt-teil-1","status":"publish","type":"post","link":"https:\/\/www.novacos-law.com\/en\/2007\/das-gkv-wettbewerbsstaerkungsgesetz-staerkung-oder-einschraenkung-des-wettbewerbs-im-arzneimittelmarkt-teil-1\/","title":{"rendered":"Das GKV-Wettbewerbsst\u00e4rkungsgesetz \u2013 St\u00e4rkung oder Einschr\u00e4nkung des Wettbewerbs im Arzneimittelmarkt? (Teil 1)"},"content":{"rendered":"<p>The article provides an overview regarding the legal changes for pharmaceutical companies based on the GKV-WSG<\/p>\n","protected":false},"excerpt":{"rendered":"<p>The article provides an overview regarding the legal changes for pharmaceutical companies based on the GKV-WSG<\/p>\n","protected":false},"author":6,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[3],"tags":[],"class_list":["post-160","post","type-post","status-publish","format-standard","hentry","category-publications"],"acf":[],"aioseo_notices":[],"aioseo_head":"\n\t\t<!-- All in One SEO 4.9.9 - aioseo.com -->\n\t<meta name=\"description\" content=\"The article provides an overview regarding the legal changes for pharmaceutical companies based on the GKV-WSG\" \/>\n\t<meta name=\"robots\" content=\"max-image-preview:large\" \/>\n\t<meta name=\"author\" content=\"Maria Heil\"\/>\n\t<link rel=\"canonical\" href=\"https:\/\/www.novacos-law.com\/en\/2007\/das-gkv-wettbewerbsstaerkungsgesetz-staerkung-oder-einschraenkung-des-wettbewerbs-im-arzneimittelmarkt-teil-1\/\" \/>\n\t<meta name=\"generator\" content=\"All in One SEO (AIOSEO) 4.9.9\" \/>\n\t\t<script type=\"application\/ld+json\" class=\"aioseo-schema\">\n\t\t\t{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.novacos-law.com\\\/en\\\/2007\\\/das-gkv-wettbewerbsstaerkungsgesetz-staerkung-oder-einschraenkung-des-wettbewerbs-im-arzneimittelmarkt-teil-1\\\/#article\",\"name\":\"Das GKV-Wettbewerbsst\\u00e4rkungsgesetz \\u2013 St\\u00e4rkung oder Einschr\\u00e4nkung des Wettbewerbs im Arzneimittelmarkt? (Teil 1) | NOVACOS\",\"headline\":\"Das GKV-Wettbewerbsst\\u00e4rkungsgesetz \\u2013 St\\u00e4rkung oder Einschr\\u00e4nkung des Wettbewerbs im Arzneimittelmarkt? (Teil 1)\",\"author\":{\"@id\":\"https:\\\/\\\/www.novacos-law.com\\\/en\\\/author\\\/mheil\\\/#author\"},\"publisher\":{\"@id\":\"https:\\\/\\\/www.novacos-law.com\\\/en\\\/#organization\"},\"datePublished\":\"2007-06-30T20:26:45+02:00\",\"dateModified\":\"2016-03-30T20:28:10+02:00\",\"inLanguage\":\"en-GB\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.novacos-law.com\\\/en\\\/2007\\\/das-gkv-wettbewerbsstaerkungsgesetz-staerkung-oder-einschraenkung-des-wettbewerbs-im-arzneimittelmarkt-teil-1\\\/#webpage\"},\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.novacos-law.com\\\/en\\\/2007\\\/das-gkv-wettbewerbsstaerkungsgesetz-staerkung-oder-einschraenkung-des-wettbewerbs-im-arzneimittelmarkt-teil-1\\\/#webpage\"},\"articleSection\":\"Publications\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.novacos-law.com\\\/en\\\/2007\\\/das-gkv-wettbewerbsstaerkungsgesetz-staerkung-oder-einschraenkung-des-wettbewerbs-im-arzneimittelmarkt-teil-1\\\/#breadcrumblist\",\"itemListElement\":[{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/www.novacos-law.com\\\/en#listItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.novacos-law.com\\\/en\",\"nextItem\":{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/www.novacos-law.com\\\/en\\\/category\\\/publications\\\/#listItem\",\"name\":\"Publications\"}},{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/www.novacos-law.com\\\/en\\\/category\\\/publications\\\/#listItem\",\"position\":2,\"name\":\"Publications\",\"item\":\"https:\\\/\\\/www.novacos-law.com\\\/en\\\/category\\\/publications\\\/\",\"nextItem\":{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/www.novacos-law.com\\\/en\\\/2007\\\/das-gkv-wettbewerbsstaerkungsgesetz-staerkung-oder-einschraenkung-des-wettbewerbs-im-arzneimittelmarkt-teil-1\\\/#listItem\",\"name\":\"Das GKV-Wettbewerbsst\\u00e4rkungsgesetz \\u2013 St\\u00e4rkung oder Einschr\\u00e4nkung des Wettbewerbs im Arzneimittelmarkt? (Teil 1)\"},\"previousItem\":{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/www.novacos-law.com\\\/en#listItem\",\"name\":\"Home\"}},{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/www.novacos-law.com\\\/en\\\/2007\\\/das-gkv-wettbewerbsstaerkungsgesetz-staerkung-oder-einschraenkung-des-wettbewerbs-im-arzneimittelmarkt-teil-1\\\/#listItem\",\"position\":3,\"name\":\"Das GKV-Wettbewerbsst\\u00e4rkungsgesetz \\u2013 St\\u00e4rkung oder Einschr\\u00e4nkung des Wettbewerbs im Arzneimittelmarkt? (Teil 1)\",\"previousItem\":{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/www.novacos-law.com\\\/en\\\/category\\\/publications\\\/#listItem\",\"name\":\"Publications\"}}]},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/www.novacos-law.com\\\/en\\\/#organization\",\"name\":\"Novacos Law\",\"description\":\"Heil \\u2022 H\\u00fcbner \\u2022 Natz \\u2022 Oeben Partnerschaft mbB\",\"url\":\"https:\\\/\\\/www.novacos-law.com\\\/en\\\/\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.novacos-law.com\\\/en\\\/author\\\/mheil\\\/#author\",\"url\":\"https:\\\/\\\/www.novacos-law.com\\\/en\\\/author\\\/mheil\\\/\",\"name\":\"Maria Heil\",\"image\":{\"@type\":\"ImageObject\",\"@id\":\"https:\\\/\\\/www.novacos-law.com\\\/en\\\/2007\\\/das-gkv-wettbewerbsstaerkungsgesetz-staerkung-oder-einschraenkung-des-wettbewerbs-im-arzneimittelmarkt-teil-1\\\/#authorImage\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/2b4b63a50b72e9a07e921c072b756cdeea932196118f4d8a2f4bfa94dceaaacf?s=96&d=mm&r=g\",\"width\":96,\"height\":96,\"caption\":\"Maria Heil\"}},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.novacos-law.com\\\/en\\\/2007\\\/das-gkv-wettbewerbsstaerkungsgesetz-staerkung-oder-einschraenkung-des-wettbewerbs-im-arzneimittelmarkt-teil-1\\\/#webpage\",\"url\":\"https:\\\/\\\/www.novacos-law.com\\\/en\\\/2007\\\/das-gkv-wettbewerbsstaerkungsgesetz-staerkung-oder-einschraenkung-des-wettbewerbs-im-arzneimittelmarkt-teil-1\\\/\",\"name\":\"Das GKV-Wettbewerbsst\\u00e4rkungsgesetz \\u2013 St\\u00e4rkung oder Einschr\\u00e4nkung des Wettbewerbs im Arzneimittelmarkt? (Teil 1) | NOVACOS\",\"description\":\"The article provides an overview regarding the legal changes for pharmaceutical companies based on the GKV-WSG\",\"inLanguage\":\"en-GB\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.novacos-law.com\\\/en\\\/#website\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.novacos-law.com\\\/en\\\/2007\\\/das-gkv-wettbewerbsstaerkungsgesetz-staerkung-oder-einschraenkung-des-wettbewerbs-im-arzneimittelmarkt-teil-1\\\/#breadcrumblist\"},\"author\":{\"@id\":\"https:\\\/\\\/www.novacos-law.com\\\/en\\\/author\\\/mheil\\\/#author\"},\"creator\":{\"@id\":\"https:\\\/\\\/www.novacos-law.com\\\/en\\\/author\\\/mheil\\\/#author\"},\"datePublished\":\"2007-06-30T20:26:45+02:00\",\"dateModified\":\"2016-03-30T20:28:10+02:00\"},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.novacos-law.com\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/www.novacos-law.com\\\/en\\\/\",\"name\":\"Novacos Law\",\"description\":\"Heil \\u2022 H\\u00fcbner \\u2022 Natz \\u2022 Oeben Partnerschaft mbB\",\"inLanguage\":\"en-GB\",\"publisher\":{\"@id\":\"https:\\\/\\\/www.novacos-law.com\\\/en\\\/#organization\"}}]}\n\t\t<\/script>\n\t\t<!-- All in One SEO -->\n\n","aioseo_head_json":{"title":"Das GKV-Wettbewerbsst\u00e4rkungsgesetz \u2013 St\u00e4rkung oder Einschr\u00e4nkung des Wettbewerbs im Arzneimittelmarkt? (Teil 1) | NOVACOS","description":"The article provides an overview regarding the legal changes for pharmaceutical companies based on the GKV-WSG","canonical_url":"https:\/\/www.novacos-law.com\/en\/2007\/das-gkv-wettbewerbsstaerkungsgesetz-staerkung-oder-einschraenkung-des-wettbewerbs-im-arzneimittelmarkt-teil-1\/","robots":"max-image-preview:large","keywords":"","webmasterTools":{"miscellaneous":""},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.novacos-law.com\/en\/2007\/das-gkv-wettbewerbsstaerkungsgesetz-staerkung-oder-einschraenkung-des-wettbewerbs-im-arzneimittelmarkt-teil-1\/#article","name":"Das GKV-Wettbewerbsst\u00e4rkungsgesetz \u2013 St\u00e4rkung oder Einschr\u00e4nkung des Wettbewerbs im Arzneimittelmarkt? (Teil 1) | NOVACOS","headline":"Das GKV-Wettbewerbsst\u00e4rkungsgesetz \u2013 St\u00e4rkung oder Einschr\u00e4nkung des Wettbewerbs im Arzneimittelmarkt? (Teil 1)","author":{"@id":"https:\/\/www.novacos-law.com\/en\/author\/mheil\/#author"},"publisher":{"@id":"https:\/\/www.novacos-law.com\/en\/#organization"},"datePublished":"2007-06-30T20:26:45+02:00","dateModified":"2016-03-30T20:28:10+02:00","inLanguage":"en-GB","mainEntityOfPage":{"@id":"https:\/\/www.novacos-law.com\/en\/2007\/das-gkv-wettbewerbsstaerkungsgesetz-staerkung-oder-einschraenkung-des-wettbewerbs-im-arzneimittelmarkt-teil-1\/#webpage"},"isPartOf":{"@id":"https:\/\/www.novacos-law.com\/en\/2007\/das-gkv-wettbewerbsstaerkungsgesetz-staerkung-oder-einschraenkung-des-wettbewerbs-im-arzneimittelmarkt-teil-1\/#webpage"},"articleSection":"Publications"},{"@type":"BreadcrumbList","@id":"https:\/\/www.novacos-law.com\/en\/2007\/das-gkv-wettbewerbsstaerkungsgesetz-staerkung-oder-einschraenkung-des-wettbewerbs-im-arzneimittelmarkt-teil-1\/#breadcrumblist","itemListElement":[{"@type":"ListItem","@id":"https:\/\/www.novacos-law.com\/en#listItem","position":1,"name":"Home","item":"https:\/\/www.novacos-law.com\/en","nextItem":{"@type":"ListItem","@id":"https:\/\/www.novacos-law.com\/en\/category\/publications\/#listItem","name":"Publications"}},{"@type":"ListItem","@id":"https:\/\/www.novacos-law.com\/en\/category\/publications\/#listItem","position":2,"name":"Publications","item":"https:\/\/www.novacos-law.com\/en\/category\/publications\/","nextItem":{"@type":"ListItem","@id":"https:\/\/www.novacos-law.com\/en\/2007\/das-gkv-wettbewerbsstaerkungsgesetz-staerkung-oder-einschraenkung-des-wettbewerbs-im-arzneimittelmarkt-teil-1\/#listItem","name":"Das GKV-Wettbewerbsst\u00e4rkungsgesetz \u2013 St\u00e4rkung oder Einschr\u00e4nkung des Wettbewerbs im Arzneimittelmarkt? (Teil 1)"},"previousItem":{"@type":"ListItem","@id":"https:\/\/www.novacos-law.com\/en#listItem","name":"Home"}},{"@type":"ListItem","@id":"https:\/\/www.novacos-law.com\/en\/2007\/das-gkv-wettbewerbsstaerkungsgesetz-staerkung-oder-einschraenkung-des-wettbewerbs-im-arzneimittelmarkt-teil-1\/#listItem","position":3,"name":"Das GKV-Wettbewerbsst\u00e4rkungsgesetz \u2013 St\u00e4rkung oder Einschr\u00e4nkung des Wettbewerbs im Arzneimittelmarkt? (Teil 1)","previousItem":{"@type":"ListItem","@id":"https:\/\/www.novacos-law.com\/en\/category\/publications\/#listItem","name":"Publications"}}]},{"@type":"Organization","@id":"https:\/\/www.novacos-law.com\/en\/#organization","name":"Novacos Law","description":"Heil \u2022 H\u00fcbner \u2022 Natz \u2022 Oeben Partnerschaft mbB","url":"https:\/\/www.novacos-law.com\/en\/"},{"@type":"Person","@id":"https:\/\/www.novacos-law.com\/en\/author\/mheil\/#author","url":"https:\/\/www.novacos-law.com\/en\/author\/mheil\/","name":"Maria Heil","image":{"@type":"ImageObject","@id":"https:\/\/www.novacos-law.com\/en\/2007\/das-gkv-wettbewerbsstaerkungsgesetz-staerkung-oder-einschraenkung-des-wettbewerbs-im-arzneimittelmarkt-teil-1\/#authorImage","url":"https:\/\/secure.gravatar.com\/avatar\/2b4b63a50b72e9a07e921c072b756cdeea932196118f4d8a2f4bfa94dceaaacf?s=96&d=mm&r=g","width":96,"height":96,"caption":"Maria Heil"}},{"@type":"WebPage","@id":"https:\/\/www.novacos-law.com\/en\/2007\/das-gkv-wettbewerbsstaerkungsgesetz-staerkung-oder-einschraenkung-des-wettbewerbs-im-arzneimittelmarkt-teil-1\/#webpage","url":"https:\/\/www.novacos-law.com\/en\/2007\/das-gkv-wettbewerbsstaerkungsgesetz-staerkung-oder-einschraenkung-des-wettbewerbs-im-arzneimittelmarkt-teil-1\/","name":"Das GKV-Wettbewerbsst\u00e4rkungsgesetz \u2013 St\u00e4rkung oder Einschr\u00e4nkung des Wettbewerbs im Arzneimittelmarkt? (Teil 1) | NOVACOS","description":"The article provides an overview regarding the legal changes for pharmaceutical companies based on the GKV-WSG","inLanguage":"en-GB","isPartOf":{"@id":"https:\/\/www.novacos-law.com\/en\/#website"},"breadcrumb":{"@id":"https:\/\/www.novacos-law.com\/en\/2007\/das-gkv-wettbewerbsstaerkungsgesetz-staerkung-oder-einschraenkung-des-wettbewerbs-im-arzneimittelmarkt-teil-1\/#breadcrumblist"},"author":{"@id":"https:\/\/www.novacos-law.com\/en\/author\/mheil\/#author"},"creator":{"@id":"https:\/\/www.novacos-law.com\/en\/author\/mheil\/#author"},"datePublished":"2007-06-30T20:26:45+02:00","dateModified":"2016-03-30T20:28:10+02:00"},{"@type":"WebSite","@id":"https:\/\/www.novacos-law.com\/en\/#website","url":"https:\/\/www.novacos-law.com\/en\/","name":"Novacos Law","description":"Heil \u2022 H\u00fcbner \u2022 Natz \u2022 Oeben Partnerschaft mbB","inLanguage":"en-GB","publisher":{"@id":"https:\/\/www.novacos-law.com\/en\/#organization"}}]}},"aioseo_meta_data":{"post_id":"160","title":null,"description":null,"keywords":null,"keyphrases":null,"primary_term":null,"canonical_url":null,"og_title":null,"og_description":null,"og_object_type":"default","og_image_type":"default","og_image_url":null,"og_image_width":null,"og_image_height":null,"og_image_custom_url":null,"og_image_custom_fields":null,"og_video":null,"og_custom_url":null,"og_article_section":null,"og_article_tags":null,"twitter_use_og":false,"twitter_card":"default","twitter_image_type":"default","twitter_image_url":null,"twitter_image_custom_url":null,"twitter_image_custom_fields":null,"twitter_title":null,"twitter_description":null,"schema":{"blockGraphs":[],"customGraphs":[],"default":{"data":{"Article":[],"Course":[],"Dataset":[],"FAQPage":[],"Movie":[],"Person":[],"Product":[],"ProductReview":[],"Car":[],"Recipe":[],"Service":[],"SoftwareApplication":[],"WebPage":[]},"graphName":"","isEnabled":true},"graphs":[]},"schema_type":null,"schema_type_options":null,"pillar_content":false,"robots_default":true,"robots_noindex":false,"robots_noarchive":false,"robots_nosnippet":false,"robots_nofollow":false,"robots_noimageindex":false,"robots_noodp":false,"robots_notranslate":false,"robots_max_snippet":null,"robots_max_videopreview":null,"robots_max_imagepreview":"large","priority":null,"frequency":null,"location":null,"local_seo":null,"breadcrumb_settings":null,"limit_modified_date":false,"ai":null,"created":"2020-12-21 12:16:30","updated":"2025-07-25 08:17:44","seo_analyzer_scan_date":null},"aioseo_breadcrumb":"<div class=\"aioseo-breadcrumbs\"><span class=\"aioseo-breadcrumb\">\n\t\t\t<a href=\"https:\/\/www.novacos-law.com\/en\" title=\"Home\">Home<\/a>\n\t\t<\/span><span class=\"aioseo-breadcrumb-separator\">&raquo;<\/span><span class=\"aioseo-breadcrumb\">\n\t\t\t<a href=\"https:\/\/www.novacos-law.com\/en\/category\/publications\/\" title=\"Publications\">Publications<\/a>\n\t\t<\/span><span class=\"aioseo-breadcrumb-separator\">&raquo;<\/span><span class=\"aioseo-breadcrumb\">\n\t\t\tDas GKV-Wettbewerbsst\u00e4rkungsgesetz \u2013 St\u00e4rkung oder Einschr\u00e4nkung des Wettbewerbs im Arzneimittelmarkt? (Teil 1)\n\t\t<\/span><\/div>","aioseo_breadcrumb_json":[{"label":"Home","link":"https:\/\/www.novacos-law.com\/en"},{"label":"Publications","link":"https:\/\/www.novacos-law.com\/en\/category\/publications\/"},{"label":"Das GKV-Wettbewerbsst\u00e4rkungsgesetz \u2013 St\u00e4rkung oder Einschr\u00e4nkung des Wettbewerbs im Arzneimittelmarkt? (Teil 1)","link":"https:\/\/www.novacos-law.com\/en\/2007\/das-gkv-wettbewerbsstaerkungsgesetz-staerkung-oder-einschraenkung-des-wettbewerbs-im-arzneimittelmarkt-teil-1\/"}],"_links":{"self":[{"href":"https:\/\/www.novacos-law.com\/en\/wp-json\/wp\/v2\/posts\/160","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.novacos-law.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.novacos-law.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.novacos-law.com\/en\/wp-json\/wp\/v2\/users\/6"}],"replies":[{"embeddable":true,"href":"https:\/\/www.novacos-law.com\/en\/wp-json\/wp\/v2\/comments?post=160"}],"version-history":[{"count":0,"href":"https:\/\/www.novacos-law.com\/en\/wp-json\/wp\/v2\/posts\/160\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.novacos-law.com\/en\/wp-json\/wp\/v2\/media?parent=160"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.novacos-law.com\/en\/wp-json\/wp\/v2\/categories?post=160"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.novacos-law.com\/en\/wp-json\/wp\/v2\/tags?post=160"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}